Kewaunee Scientific CorporationKEQUNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, above historical average, strong compound growth.
Left:
|
|
|
|

Operating cash flow minus capital expenditures

Latest
$12.62M
↑ 461% above average
Average (9y)
$2.25M
Historical baseline
Range
High:$15.19M
Low:$-9.79M
CAGR
+10.6%
Consistent expansion
PeriodValueChange
2025$12.62M-16.9%
2024$15.19M+291.4%
2023$-7.94M+18.9%
2022$-9.79M-559.5%
2021$-1.49M-187.6%
2020$1.70M+198.4%
2019$-1.72M-712.7%
2018$-212000.00-102.3%
2017$9.05M+78.0%
2016$5.08M-